1. Home
  2. PGEN vs NXJ Comparison

PGEN vs NXJ Comparison

Compare PGEN & NXJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • NXJ
  • Stock Information
  • Founded
  • PGEN 1998
  • NXJ 1999
  • Country
  • PGEN United States
  • NXJ United States
  • Employees
  • PGEN N/A
  • NXJ N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • NXJ Finance/Investors Services
  • Sector
  • PGEN Health Care
  • NXJ Finance
  • Exchange
  • PGEN Nasdaq
  • NXJ Nasdaq
  • Market Cap
  • PGEN 493.0M
  • NXJ 503.5M
  • IPO Year
  • PGEN N/A
  • NXJ N/A
  • Fundamental
  • Price
  • PGEN $3.89
  • NXJ $12.73
  • Analyst Decision
  • PGEN Buy
  • NXJ
  • Analyst Count
  • PGEN 5
  • NXJ 0
  • Target Price
  • PGEN $7.50
  • NXJ N/A
  • AVG Volume (30 Days)
  • PGEN 4.5M
  • NXJ 74.9K
  • Earning Date
  • PGEN 11-13-2025
  • NXJ 01-01-0001
  • Dividend Yield
  • PGEN N/A
  • NXJ 3.27%
  • EPS Growth
  • PGEN N/A
  • NXJ N/A
  • EPS
  • PGEN N/A
  • NXJ N/A
  • Revenue
  • PGEN $4,340,000.00
  • NXJ N/A
  • Revenue This Year
  • PGEN $249.10
  • NXJ N/A
  • Revenue Next Year
  • PGEN $710.03
  • NXJ N/A
  • P/E Ratio
  • PGEN N/A
  • NXJ N/A
  • Revenue Growth
  • PGEN N/A
  • NXJ N/A
  • 52 Week Low
  • PGEN $0.65
  • NXJ $10.06
  • 52 Week High
  • PGEN $5.23
  • NXJ $12.24
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 49.47
  • NXJ 60.55
  • Support Level
  • PGEN $3.86
  • NXJ $12.66
  • Resistance Level
  • PGEN $4.35
  • NXJ $12.75
  • Average True Range (ATR)
  • PGEN 0.27
  • NXJ 0.08
  • MACD
  • PGEN -0.04
  • NXJ -0.02
  • Stochastic Oscillator
  • PGEN 23.33
  • NXJ 84.62

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

Share on Social Networks: